Trial intelligence / Profile preview

Tricilest vs Oilezz for mild to moderate acne vulgaris

NCT01466673Phase 4Completed

Sponsor
Janssen Pharmaceutical
Start
Dec 2008
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Tricilest in acne vulgaris, sponsored by Janssen Pharmaceutical. Started Dec 2008; status: completed.

02

Drugs

Tricilest
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT01466673.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01466673.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call